MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
776.31
+4.44
+0.58%
After Hours: 774.53 -1.78 -0.23% 16:27 01/02 EST
OPEN
774.25
PREV CLOSE
771.87
HIGH
779.75
LOW
765.77
VOLUME
464.42K
TURNOVER
--
52 WEEK HIGH
792.77
52 WEEK LOW
475.17
MARKET CAP
81.59B
P/E (TTM)
18.58
1D
5D
1M
3M
1Y
5Y
1D
Will ANIP's Rare Disease Franchise Maintain Momentum in 2026?
NASDAQ · 6h ago
REGN Soars 41% in Six Months: Is There More Upside Potential in 2026?
NASDAQ · 7h ago
Outlook Therapeutics Stock Sinks After FDA Rejects Eye Drug Again
Benzinga · 8h ago
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
BAYRY's 2025 Revival: Will the Momentum Continue in 2026?
NASDAQ · 12/31/2025 13:10
3 Reasons to Avoid REGN and 1 Stock to Buy Instead
Barchart · 12/31/2025 10:32
It's Earnings Warning Season. How to Profit From Others' Misery.
Barron‘s · 12/31/2025 06:30
Regeneron Advances Phase 3 Antibody Trial in Birch Pollen Eye Allergy: What Investors Should Know
TipRanks · 12/30/2025 16:30
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.